Paul Matteis Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
29%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
55.6%
Neutral
44.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Maintained
| $77 |
2%
downside
| 1 | – |
–
| 26 Feb ‘26 6 days ago |
|
|
|
Hold
Maintained
| $24 |
7%
upside
| 2 | – |
–
| 26 Feb ‘26 6 days ago |
|
|
|
Hold
Maintained
| $466 |
2%
downside
| 1 | – |
–
| 13 Feb ‘26 19 days ago |
|
|
|
Buy
Maintained
| $40 |
343%
upside
| 1 | -3.9% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $188 |
43%
upside
| 1 | -0.79% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $35 |
46%
upside
| 1 | +27% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $39 |
167%
upside
| 1 | +36% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $508 |
59%
upside
| 1 | +12% |
0
%
| 11 Dec ‘25 2 months ago |
|